Материалов:
1 081 645

Репозиториев:
30

Авторов:
761 409

По вашему запросу найдено документов: 7332

Страница 1 из 734

Vaccination in rheumatology (the 2019 update of EULAR recommendations) [Вакцинация в ревматологии – 2019 (по материалам рекомендаций EULAR)]
Belov B.S.
Rheumatism (EULAR) recommendations for vaccination in adult patients with IRDs. It discusses the safety
Immunogenicity assessment of pegfilgrastim in patients with breast cancer
Medvedev Y.V., Kolganova M.A., Sas O.A., Komarov T.N., Fisher E.N., Shohin I.E., Ammour Y.I.
. Immunogenicity is a potential concern for any biological product, thus, its assessment is one of the most
Safety and immunogenicity of the gamtbvac, the recombinant subunit tuberculosis vaccine candidate: A phase II, multi-center, double-blind, randomized, placebo-controlled study
Tkachuk A.P., Bykonia E.N., Popova L.I., Kleymenov D.A., Semashko M.A., Chulanov V.P., Fitilev S.B., Maksimov S.L., Smolyarchuk E.A., Manuylov V.A., Vasina D.V., Gushchin V.A., Gintsburg A.L.
-controlled study in parallel groups in healthy adults to evaluate the safety and immunogenicity of GamTBvac in 180
Safety and immunogenicity of trivalent inactivated influenza vaccine in adults 60 years of age and older: a phase II, a randomized, comparative trial in Kazakhstan
Sarsenbayeva G.
versus commercial vaccine VAXIGRIP® for immunogenicity and safety in the course of clinical trial phase
Influenza burden, prevention, and treatment in asthma-A scoping review by the EAACI Influenza in asthma task force
Schwarze J.
; vaccination coverage; immunogenicity, efficacy, effectiveness, and safety of influenza vaccines
Comparative analysis of pharmacokinetic parameters, bioequivalence, safety, tolerability and immunogenicity of semaglutide-based drug for the treatment of obesity; [Сравнительное исследование фармакокинетических параметров, биоэквивалентности, безопасности, переносимости и иммуногенности лекарственного препарата для лечения ожирения на основе семаглутида]
Ametov A.S., Bely P.A., Zaslavskaya K.Y., Rogozhina E.A., Shcherbakova V.S., Kazaishvili Y.G., Taganov A.V., Bodrova T.G., Mishshenko E.S., Koryanova K.N., Shcherbakova L.I.
pharmacokinetic parameters, bioequivalence, safety, tolerability and immunogenicity of the Velgia® (WRYC12301
Immunogenicity and safety of a trivalent subunit immunoadjuvant influenza vaccine in children with type 1 diabetes: Results of a prospective comparative study
Tarasova A.A.
: Our aim was to assess immunogenicity and safety of a trivalent subunit immunoadjuvant influenza
Live attenuated influenza H7N3 vaccine is safe, immunogenic and confers protection in animal models
Rekstin A.
influenza A vaccine (LAIV) candidate in various animal models. Objectives: To study safety, immunogenicity
Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model
Korenkov D.A.
were immunogenic as high neutralizing and hemagglutination inhibition serum antibody titers were
Use of live attenuated influenza vaccines in young children in resource-poor settings
Isakova-Sivak I.
drug safety

Страница 1 из 734

Фасеты

Партнеры

КФУ
ТГУ
Elpub
СФУ
Webpublishers

Индексация

BASE
WorldCat
OpenAIRE
EDS
core